BIO KEY INTERNATIONAL INC
BKYINasdaqTechnology · Services-Prepackaged Software · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | |
|---|---|---|---|---|---|---|
| Revenue | $6.9M | $2.2M | $7.0M | $5.1M | $2.8M | $2.3M |
| Operating income | −$4.0M | −$1.8M | −$9.9M | −$4.9M | −$5.2M | −$1.1M |
| Net income | −$4.3M | −$1.7M | −$11.9M | −$5.1M | −$9.7M | −$14.6M |
| Total assets | $8.6M | $4.5M | $11.3M | $17.8M | $22.5M | $2.5M |
| Total liabilities | $4.8M | $3.5M | $6.0M | $2.2M | $2.2M | $4.8M |
| Equity | $3.8M | $3.8M | $5.3M | $15.6M | $20.3M | −$2.3M |
| EPS (diluted) | $-2.09 | $-3.04 | $-27.26 | $-0.65 | — | — |
| Shares out. | 1.8M | 9.2M | 8.4M | 7.8M | 21.2M | 14.0M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2024- Operating margin
- −57.9%
- Net margin
- −62.1%
- Return on equity
- −114.0%
- Return on assets
- −49.9%
- Return on capital (ROCE)
- −98.7%
- Liabilities / assets
- 56.2%
- Debt / equity
- 1.28×
- Book value / share
- $2.08
- Revenue growth (YoY)
- 217.3%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2024- Altman Z″ (distress)
- -53.27distress
- Accruals / assets
- −16.1%clean
- Beneish M-Score
- -3.20normal
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 3 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 18, 2026
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2026
- NT 10-Kmissed a reporting deadline ↗Apr 1, 2025
- NT 10-Qmissed a reporting deadline ↗May 16, 2024
- NT 10-Kmissed a reporting deadline ↗Apr 2, 2024
- NT 10-Qmissed a reporting deadline ↗Nov 15, 2023
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Armistice Capital, LlcPassive (13G)Aug 15, 2025
- Streeterville Capital LlcPassive (13G)Jun 10, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Lacous Mira KOfficer — Chief Technology Officer | Dec 31, 2025 | Grant | 2,500 | $0.46 |
| Sullivan James DavidOfficer — Chief Legal Officer | Dec 31, 2025 | Grant | 2,500 | $0.46 |
| Depasquale Michael WOfficer — Chief Executive Officer | Dec 31, 2025 | Grant | 2,500 | $0.46 |
| Depasquale Michael WOfficer — Chief Executive Officer | Sep 15, 2025 | Buy | 2,500 | $0.75 |
| Welch Cecilia COfficer — Chief Financial Officer | Sep 2, 2025 | Grant | 35,000 | $0.00 |
| Sullivan James DavidOfficer — Chief Legal Officer | Sep 2, 2025 | Grant | 40,000 | $0.00 |
| Lacous Mira KOfficer — Chief Technology Officer | Sep 2, 2025 | Grant | 25,000 | $0.00 |
| Depasquale Michael WOfficer — Chief Executive Officer | Sep 2, 2025 | Grant | 45,000 | $0.00 |
| Sullivan James DavidOfficer — Chief Legal Officer | Aug 22, 2025 | Buy | 10,000 | $0.77 |
| Depasquale Michael WOfficer — Chief Executive Officer | Jun 30, 2025 | Grant | 139 | $0.70 |
| Sullivan James DavidOfficer — Chief Legal Officer | Jun 30, 2025 | Grant | 139 | $0.70 |
| Lacous Mira KOfficer — Chief Technology Officer | Jun 30, 2025 | Grant | 139 | $0.70 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 41,230 | 1.0 | +109.9% |
| Apr 30, 2026 | 19,645 | 1.0 | -86.4% |
| Apr 15, 2026 | 144,429 | 1.6 | -20.5% |
| Mar 31, 2026 | 181,682 | 1.0 | +14.7% |
| Mar 13, 2026 | 158,340 | 1.0 | -29.4% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 18, 2026
- Delisting / listing-standard notice · Regulation FD disclosureMay 12, 2026
- Modified shareholder rights · Amended charter or bylaws · Other material eventApr 29, 2026
- Shareholder voteApr 24, 2026
- Delisting / listing-standard notice · Regulation FD disclosureApr 22, 2026
- Results of operationsApr 20, 2026
- Results of operationsMar 31, 2026
- Results of operationsMar 4, 2026
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- NT 10-QFORM NT 10-QMay 18, 2026
- 8-KFORM 8-KMay 18, 2026
- 8-KFORM 8-KMay 12, 2026
- 8-KFORM 8-KApr 29, 2026
- 8-KFORM 8-KApr 24, 2026
- 8-KFORM 8-KApr 22, 2026
- 8-KFORM 8-KApr 20, 2026
- NT 10-KFORM NT 10-KMar 31, 2026
- 8-KFORM 8-KMar 31, 2026
- DEF 14AFORM DEF 14AMar 16, 2026
- PRE 14AFORM PRE 14AMar 6, 2026
- 8-KFORM 8-KMar 4, 2026
- 4FORM 4Jan 5, 2026
- 4FORM 4Jan 5, 2026
- 4FORM 4Jan 5, 2026